HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Does correction of the friedewald formula using lipoprotein(a) change our estimation of ischemic heart disease risk? The Quebec Cardiovascular Study.

AbstractBACKGROUND:
LDL-cholesterol is usually calculated using the Friedewald formula. This calculation method does not take into account the presence of Lp(a), which is associated with LDL-cholesterol. Dahlen has suggested that the Friedewald formula should be modified to account for Lp(a) associated cholesterol. This study was undertaken to determine if correction of the Friedewald formula would result in a better evaluation of ischemic heart disease (IHD) risk.
METHODS:
2222 men free from IHD were prospectively followed for 5 years for the appearance of myocardial infarction, coronary insufficiency or coronary death. At the baseline evaluation all had a complete fasting lipid profile which included Lp(a) determinations. LDL-cholesterol levels were calculated from total cholesterol, total triglycerides and HDL-cholesterol using the Friedewald formula and also using the Dahlen modification of the Friedewald formula.
RESULTS:
During the follow-up there were 89 first IHD events. Both types of LDL-cholesterol calculations showed that the last tertile of the LDL-cholesterol distribution in comparison to the first tertile, doubles the relative risk (RR: 2.15; 95% confidence limits: 1.23-3.75) using the Friedewald formula (RR: 2.18; 95% confidence limits: 1.25-3.81) using the Dahlen modification. Lp(a) levels were not an independent predictor of IHD risk.
CONCLUSION:
Modification of the Friedewald formula to account for Lp(a) levels does not improve our evaluation of IHD risk.
AuthorsBernard Cantin, Benoît Lamarche, Jean-Pierre Després, Gilles R Dagenais
JournalAtherosclerosis (Atherosclerosis) Vol. 163 Issue 2 Pg. 261-7 (Aug 2002) ISSN: 0021-9150 [Print] Ireland
PMID12052472 (Publication Type: Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Cholesterol, LDL
  • Lipoprotein(a)
Topics
  • Adult
  • Cholesterol, LDL (blood)
  • Coronary Artery Disease
  • Follow-Up Studies
  • Humans
  • Hypercholesterolemia
  • Lipoprotein(a) (blood)
  • Male
  • Mathematics
  • Middle Aged
  • Myocardial Ischemia (epidemiology, etiology)
  • Predictive Value of Tests
  • Prospective Studies
  • Reference Values
  • Risk
  • Risk Factors
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: